Tamil Nadu's CMCHIS successfully treats Thalassemia-affected children at Apollo Cancer Centre, Chennai

Chennai, 31st May 2023: Apollo Cancer Centre in Chennai, in partnership with the Tamil Nadu Government, celebrated World Thalassemia Month by successfully treating the highest number of Thalassemia-affected children under the Tamil Nadu CM's Comprehensive Health Insurance Scheme. The event was attended by Shri M Govinda Rao IAS, Dr Ravi Babu, Joint Director of Medical Services – CMCHIS Tamil Nadu Government, District Revenue Officer Mr. Mohan Chandran, and Dr Preetha Reddy - Executive Vice Chairperson, Apollo Hospitals Enterprise Limited, Clinical team, and Thalassemia beneficiaries under TNCMCHIS. One of the success stories is that of 6-year-old Shreya, who needed monthly blood transfusions to ensure her body had enough hemoglobin to supply oxygen. Despite no stem cell match among family members or unrelated donors, the expert clinical team successfully removed anti-bodies and proceeded with the BMT, which was successfully done under TNCMCHIS at Apollo Cancer Centre, Chennai. Shreya is now thalassemia-free.

This success story highlights the importance of BMT and timely financial aid for underprivileged patients and families facing monthly transfusion disruptions. Dr. Revathi Raj, Senior Consultant at Apollo Cancer Centre, Chennai, reported that around 165 young patients affected by Thalassemia major have benefitted from bone marrow transplantation (BMTs) at the centre. With support from the Tamil Nadu Government, the Centre has managed to treat these children who require specialized and intensive care. The Chief Minister's Comprehensive Health Insurance Scheme in Tamil Nadu has enabled timely medical intervention for several underprivileged children suffering from Thalassemia, Primary Immune Deficiencies, and genetic disorders. Dr. Preetha Reddy, Vice Chairperson of Apollo Hospitals Enterprise Limited, expressed gratitude to the Ministry of Health, Government of Tamil Nadu, for their continued support in Apollo's mission to bring international-standard healthcare to every individual. BMT is the only curative option for Thalassemia major, Aplastic Anemia, and Primary Immune Deficiencies.

Comments

Popular posts from this blog

First DPL match was won by US Consulate Staff Team

TATA AIG Strengthens Tamil Nadu Health Insurance Portfolio with New Riders amid Strong Growth

Apollo Cancer Centers now introduces Made in India, CAR T Cell Program